Related references
Note: Only part of the references are listed.Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2012 update
Yun-Fan Liaw et al.
HEPATOLOGY INTERNATIONAL (2012)
Efficacy of thymosin α-1 plus peginterferon α-2a combination therapy compared with peginterferon α-2a monotherapy in HBeAg-positive chronic hepatitis B: A prospective, multicenter, randomized, open-label study
Bo Hyun Kim et al.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2012)
From lab to bedside: emerging clinical applications of thymosin alpha(1)
Allan L. Goldstein et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2009)
Treatment with lamivudine versus lamivudine and thymosin alpha-I for e antigen-positive chronic hepatitis B patients: a meta-analysis
Yuan-Yuan Zhang et al.
VIROLOGY JOURNAL (2009)
Treatment with lamivudine versus lamivudine and thymosin alpha-1 for e antigen-positive chronic hepatitis B patients: a meta-analysis
Yuan-Yuan Zhang et al.
VIROLOGY JOURNAL (2009)
Comparison of the efficacy of thymosin alpha-1 and interferon alpha in the treatment of chronic hepatitis B: A meta-analysis
Yong-Feng Yang et al.
ANTIVIRAL RESEARCH (2008)
Hepatitis B virus genotype B is associated with better response to thymosin α1 therapy than genotype C
R-N. Chien et al.
JOURNAL OF VIRAL HEPATITIS (2006)
Long-term outcomes of thymosin-α1 and interferon α-2b combination therapy in patients with hepatitis B e antigen (HBeAg) negative chronic hepatitis B
M Saruc et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2003)
Thymosin-α1 increases intrahepatic NKT cells and CTLs in patients with chronic hepatitis B
S Sugahara et al.
HEPATOLOGY RESEARCH (2002)
Thymosin-α1 and famciclovir combination therapy activates T-cell response in patients with chronic hepatitis B virus infection in immune-tolerant phase
GKK Lau et al.
JOURNAL OF VIRAL HEPATITIS (2002)
Thymosin alpha 1 accelerates restoration of T cell-mediated neutralizing antibody response in immunocompromised hosts
CL Li et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2002)
The efficacy of thymosin in the treatment of chronic hepatitis B virus infection: a meta-analysis
HLY Chan et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2001)
A randomized, controlled study of thymosin-α1 therapy in patients with anti-HBe, HBV-DNA-positive chronic hepatitis B
C Zavaglia et al.
DIGESTIVE DISEASES AND SCIENCES (2000)
Share Paper
